Congenital disorder of glycosylation type IIb in an infant with developmental and epileptic encephalopathy

R K Shwetabh1, Anita Singh2, Kausik Mandal3

  • 1Neonatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

BMJ Case Reports
|November 5, 2025
PubMed

Insights

A rare congenital disorder of glycosylation (CDG) type IIb, caused by MOGS gene mutations, was identified in an infant with severe developmental delay and seizures. A mannose-based diet showed partial improvement, emphasizing early diagnosis for better outcomes.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Congenital disorders of glycosylation (CDG) are a group of rare inherited metabolic diseases affecting protein and lipid glycosylation.
  • CDG type IIb, specifically linked to MOGS gene mutations, presents with complex multisystemic symptoms, including neurological and developmental issues.
  • Early diagnosis and intervention are crucial for managing CDG, but recognition can be challenging due to overlapping symptoms with other conditions.

Purpose of the Study:

  • To report a case of a term infant with severe early-onset neurological and multisystemic symptoms.
  • To identify the genetic cause of the infant's condition using whole exome sequencing.
  • To evaluate the therapeutic effect of a mannose-based diet in managing the identified genetic disorder.

Main Methods:

  • Clinical evaluation of a term infant presenting with progressive developmental delay, seizures, feeding difficulties, and failure to thrive.
  • Comprehensive investigations including MRI, ruling out infections, metabolic acidosis, and structural brain malformations.
  • Whole exome sequencing to identify the causative genetic mutation.

Main Results:

  • The infant exhibited severe neonatal symptoms including vomiting, lethargy, seizures, neurological deterioration, hepatomegaly, nephromegaly, hypothyroidism, and auditory neuropathy.
  • MRI revealed cerebral atrophy and dilated ventricles.
  • Whole exome sequencing identified a homozygous missense mutation in the MOGS gene (c.2090T>C; p.Leu697Ser), confirming MOGS-CDG (CDG type IIb). A mannose-based diet resulted in partial clinical improvement.

Conclusions:

  • This case underscores the importance of considering neurometabolic disorders like MOGS-CDG in infants with early-onset epileptic encephalopathy and multisystem involvement.
  • Early genetic diagnosis through whole exome sequencing is critical for identifying MOGS-CDG.
  • Supportive multidisciplinary care and potentially targeted dietary interventions, such as a mannose-based diet, can help improve outcomes and guide family counseling.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
690
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K